| Literature DB >> 36168562 |
Rezan Aksoy1, Ali Karagöz2, Deniz Çevirme1, Mehmet Dedemoğlu3, Hakan Hancer1, Alev Kılıçgedik2, Murat Bülent Rabus1.
Abstract
Background: This study aims to investigate the association of progression of tricuspid regurgitation following double-valve replacement by comparing the tricuspid valve repair and no repair groups, and to analyze outcomes of patients with non-repaired mild-to-moderate tricuspid regurgitation.Entities:
Keywords: Aortic valve; mitral valve; tricuspid valve; tricuspid valve regurgitation
Year: 2022 PMID: 36168562 PMCID: PMC9473593 DOI: 10.5606/tgkdc.dergisi.2022.22553
Source DB: PubMed Journal: Turk Gogus Kalp Damar Cerrahisi Derg ISSN: 1301-5680 Impact factor: 0.704
Comparison of baseline clinical and echocardiographic parameters between the TV repair and no-TV repair groups
| All-patients (n=157) | No-TV repair group (n=78) | TV repair group (n=79) | |||||||||||
| Variables | n | % | Median | 25th-75th | n | % | Median | 25th-75th | n | % | Median | 25th-75th | |
| percentiles | percentiles | percentiles | |||||||||||
| Age (year) | 52 | 43-63 | 51 | 43.3-62 | 54 | 43-64 | 0.48 | ||||||
| Sex | 41 | 52.6 | 42 | 53.2 | 0.94 | ||||||||
| Female | 83 | 52.9 | |||||||||||
| BMI (kg/m2) | 26 | 23-29 | 26 | 23-30 | 26 | 23.5-29 | 0.93 | ||||||
| BSA (m2) | 1.79 | 1.66-1.93 | 1.77 | 1.65-1.93 | 1.82 | 1.66-1.93 | 0.27 | ||||||
| DM | 16 | 10.2 | 9 | 11.5 | 7 | 8.9 | 0.58 | ||||||
| HT | 33 | 21 | 17 | 21.8 | 16 | 20.3 | 0.81 | ||||||
| AF | 25 | 12.1 | 13 | 16.7 | 32 | 43 | <0.001 | ||||||
| Dominant diagnosis | 0.13 | ||||||||||||
| AS-MS | 21 | 13.4 | 10 | 12.8 | 11 | 13.9 | |||||||
| AR-MR | 46 | 29.3 | 17 | 21.8 | 29 | 36.7 | |||||||
| AS-MR | 48 | 30.6 | 25 | 32.1 | 23 | 29.1 | |||||||
| AR-MS | 42 | 26.8 | 26 | 33.3 | 16 | 20.3 | |||||||
| CPB (min) | 182 | 152-226 | 175 | 136-211 | 194 | 167-233 | 0.003 | ||||||
| Rheumatic aetiology | 82 | 52.2 | 40 | 51.3 | 42 | 53.2 | 0.81 | ||||||
| Echocardiographic characteristics | |||||||||||||
| EF% | 60 | 50-65 | 60 | 55-65 | 58 | 50-65 | 0.17 | ||||||
| Degree of MR | 3 | 2-4 | 3 | 2-3.5 | 3 | 2-4 | 0.14 | ||||||
| Mitral mean gradient (mmHg) | 9 | 6-14 | 7.5 | 5.25-11 | 10 | 8-17.8 | 0.008 | ||||||
| Mitral max gradient (mmHg) | 19 | 14-27 | 15.5 | 12-23 | 21.5 | 16.3-27.8 | 0.02 | ||||||
| Aortic mean gradient (mmHg) | 40 | 25-50 | 38 | 27-50 | 41 | 25-49 | 0.81 | ||||||
| Aortic max gradient (mmHg) | 61 | 44-78 | 60 | 44-75 | 64 | 43-80 | 0.62 | ||||||
| MVA (cm2, in MS) | 1.3 | 1.1-1.6 | 1.39 | 1.10-1.66 | 1.36 | 1.1-1.51 | 0.63 | ||||||
| Diameter of tricuspid annulus (cm) | 3.9 | 3.8-4 | 3.9 | 3.4-3.9 | 4 | 4-4.2 | <0.001 | ||||||
| Degree of TR (median) | 2 | 2-3 | 1 | 1-1 | 2 | 1-3 | <0.001 | ||||||
| Aortic regurgitation | 3 | 2-4 | 3 | 3-4 | 3 | 2-3.5 | 0.03 | ||||||
| Mild TR | 87 | 55.4 | 66 | 84.6 | 22 | 27.8 | <0.001 | ||||||
| Moderate | 44 | 28 | 12 | 15.4 | 32 | 40.5 | |||||||
| Severe | 26 | 16.6 | 0 | 0 | 25 | 31.6 | |||||||
| LVEDD (cm) | 5.2 | 4.7-6 | 5.2 | 4.6-6.1 | 5.2 | 4.7-5.9 | 0.36 | ||||||
| LVESD (cm) | 3.5 | 3-4.3 | 3.5 | 3-4.3 | 3.5 | 3-4.3 | 0.80 | ||||||
| IVSD (cm) | 1.1 | 1-1.3 | 1.1 | 1-1.4 | 1.1 | 1-1.3 | 0.42 | ||||||
| LAD (cm) | 4.6 | 4.2-5.1 | 4.35 | 4.2-4.8 | 4.7 | 4.4-5.2 | 0.002 | ||||||
| PAP (mmHg) | 48 | 35-60 | 40 | 35-50 | 55 | 45-65 | <0.001 | ||||||
| AVA (cm2, in AS) | 0.8 | 0.75-1.1 | 0.78 | 0.75-1.1 | 0.80 | 0.72-1.10 | 0.68 | ||||||
| TV: Tricuspid valve; BMI: Body mass index; BSA: Body surface area; DM: Diabetes mellitus; HT: Hypertension; AF: Atrial fibrillation; AS: Aortic stenosis; MS: Mitral stenosis; AR: Aortic regurgitation; MR: Mitral regurgitation; CPB: Cardiopulmonary bypass; EF: Ejection fraction; MVA: Mitral valve area; TR: Tricuspid regurgitation; LVEDD: Left ventricular end-diastolic diameter; LVESD: Left ventricular end-systolic diameter; LAD: Left-atrial diameter; PAP: Pulmonary artery pressure; AVA: Aortic valve area; IVSD: Interventricular septum diameter; Mann-Whitney-U, Categorical variables comparison with chi-square test. | |||||||||||||
Comparison of postoperative clinical and echocardiographic parameters between the TV repair and no-TV repair groups
| All patients | No-TV repair group | TV repair group | |||||||||||
| Variables | n | % | Median | 25th-75th | n | % | Median | 25th-75th | n | % | Median | 25th-75th | |
| Baseline AF-continue AF | 11 | 7 | 2 | 2.6 | 9 | 11.4 | 0.03 | ||||||
| Baseline AF-free AF | 25 | 15.9 | 9 | 11.5 | 16 | 20.3 | 0.13 | ||||||
| PVL aortic | 3 | 1.9 | 2 | 2.6 | 1 | 1.3 | 0.62 | ||||||
| PVL mitral | 3 | 1.9 | 1 | 1.3 | 2 | 2.5 | 0.99 | ||||||
| PVL combined | 1 | 0.6 | 0 | 0 | 1 | 1.3 | 0.99 | ||||||
| Valvular thrombosis aortic | 1 | 0.6 | 1 | 1.3 | 0 | 0 | 0.50 | ||||||
| Valvular thrombosis mitral | 2 | 1.3 | 0 | 0 | 2 | 2.5 | 0.49 | ||||||
| IE | 1 | 0.6 | 0 | 0 | 1 | 1.3 | 0.99 | ||||||
| In-hospital mortality | 5 | 3.2 | 3 | 3.8 | 2 | 2.5 | 0.68 | ||||||
| Late mortality | 20 | 12.7 | 7 | 9 | 13 | 16.5 | 0.16 | ||||||
| Ventilation time (h) | 13 | 9-18 | 11 | 8-14 | 15 | 10-19 | 0.005 | ||||||
| Duration of ICU (day) | 2 | 2-4 | 2 | 1-4 | 3 | 2-5 | <0.001 | ||||||
| Duration of hospital stay (day) | 11 | 8-16 | 10 | 8-15 | 12 | 8.5-16 | 0.25 | ||||||
| Follow-up duration (year) | 3.3 | 2.3-4.45 | 4.03 | 3.1-4.54 | 2.73 | 2-3.98 | <0.001 | ||||||
| Neurological complication | 19 | 12.1 | 8 | 10.3 | 11 | 13.9 | 0.48 | ||||||
| (delirium-TIA-CVO) | |||||||||||||
| Echocardiographic characteristics | |||||||||||||
| EF% | 55 | 50-65 | 60 | 50-64 | 55 | 50-65 | 0.62 | ||||||
| Mitral mean gradient (mmHg) | 6 | 4-7 | 5 | 5.5-7 | 6 | 4-7 | 0.85 | ||||||
| Mitral max gradient (mmHg) | 12 | 10-14 | 12 | 10-13 | 13 | 10-15 | 0.26 | ||||||
| Aortic mean gradient (mmHg) | 14 | 11-17 | 14 | 11-18 | 13.5 | 10.8-17 | 0.96 | ||||||
| Aortic max gradient (mmHg) | 25 | 20-31 | 25 | 20-30.5 | 25 | 20-31 | 0.86 | ||||||
| MVA (cm2) | 2.5 | 2.3-2.6 | 2.5 | 2.3-2.6 | 2.5 | 2.3-2.6 | 0.47 | ||||||
| Mild TR | 115 | 73.2 | 50 | 64.1 | 65 | 82.3 | 0.004 | ||||||
| Moderate TR | 16 | 10.2 | 14 | 17.9 | 2 | 2.5 | |||||||
| Severe TR | 26 | 16.6 | 14 | 17.9 | 12 | 15.2 | |||||||
| LVEDD (cm) | 5 | 4.6-5.4 | 4.85 | 4.60-5.40 | 5 | 4.6-5.4 | 0.26 | ||||||
| LVESD (cm) | 3.3 | 3-4 | 3.2 | 3-3.7 | 3.4 | 3-4 | 0.24 | ||||||
| IVSD (cm) | 1.1 | 1-1.2 | 1.1 | 1-1.2 | 1.1 | 1-1.2 | 0.43 | ||||||
| LAD (cm) | 4.5 | 4.2-4.8 | 4.5 | 4.2-4.8 | 4.5 | 4-4.9 | 0.63 | ||||||
| TV: Tricuspid valve; AF: Atrial fibrillation; PVL: Paravalvular leak; IE: Infective endocarditis; ICU: Intensive care unit; TIA: Transient ischemic attack; CVO: Cerebro-vascular event; EF: Ejection fraction; MVA: Mitral valve area; TR: Tricuspid regurgitation; LVEDD: Left ventricular end-diastolic diameter; LVESD: Left ventricular end-systolic diameter; IVSD: Interventricular septum diameter; LAD; Left-atrial diameter; Mann- Whitney-U, Categorical variables comparison with Chi-Square Test. | |||||||||||||
Baseline characteristics, postoperative ICU duration and hospital stay, ventilation time and mortality
| Variables | Unmatched | Matched | ||||||||||||||||
| No-TV repair group (n=78) | TV repair group (n=79) | No-TV repair group (n=76) | TV repair group (n=76) | |||||||||||||||
| n | % | Median | 25th-75th | n | % | Median | 25th-75th | n | % | Median | 25th-75th | n | % | Median | 25th-75th | |||
| Age (year) | 51 | 43-62 | 54 | 43-64 | 0.48 | 51 | 44-62 | 53 | 43-62 | 0.76 | ||||||||
| CBP (min) | 175 | 136-211 | 194 | 167-233 | 0.003 | 175 | 134-214 | 194 | 170-233 | 0.16 | ||||||||
| BSA | 1.77 | 1.65-1.93 | 1.81 | 1.66-1.93 | 0.27 | 1.79 | 1.65-1.92 | 1.81 | 1.66-1.93 | 0.14 | ||||||||
| Neurological complication (delirium-TIA-CVO) | 8 | 10.3 | 11 | 13.9 | 0.48 | 8 | 10.5 | 11 | 14.5 | 0.46 | ||||||||
| Ventilation time (h) | 11 | 8-14 | 15 | 10-19 | 0.005 | 12 | 8-15 | 15 | 10-18 | 0.08 | ||||||||
| Duration of ICU (day) | 2 | 1-4 | 3 | 2-5 | <0.001 | 2 | 1-3 | 3 | 2-5 | 0.02 | ||||||||
| Duration of hospital stay (day) | 10 | 8-15 | 12 | 8-16 | 0.25 | 11 | 8-15 | 12 | 9-16 | 0.29 | ||||||||
| In-hospital mortality | 3 | 3.8 | 2 | 2.5 | 0.68 | 3 | 3.9 | 2 | 2.6 | 0.99 | ||||||||
| Late mortality | 7 | 9 | 13 | 16.5 | 0.16 | 7 | 9.2 | 13 | 17.1 | 0.15 | ||||||||
| ICU: Intensive care unit; TV: Tricuspid valve; CBP: Cardiopulmonary bypass; TIA: Transient ischemic attack; CVO: Cerebrovascular event. | ||||||||||||||||||
Logistic regression analyses (propensity matched data); Predictive of postoperative progression of (moderate-to-severe) TR in the subgroup (the patients who had preoperative mild-to-moderate TR in the no-TV repair group)
| Univariable | Multivariable | |||||
| Variables | OR | IQR | OR | IQR | ||
| Age (from 42-62) | 1.02 | 0.98-1.06 | 0.27 | |||
| Sex (male reference) | 2.45 | 0.92-6.53 | 0.07 | 1.70 | 0.59-4.95 | 0.32 |
| Baseline/continue AF | 1.84 | 0.11-30.74 | 0.67 | 1.30 | 0.06-27.25 | 0.86 |
| Baseline EF% (from 51 to 65%) | 1.02 | 0.96-1.07 | 0.58 | |||
| Baseline diameter of tricuspid annulus (from 3.4-3.9) | 1.60 | 0.38-6.65 | 0.52 | 2.66 | 0.59-11.95 | 0.20 |
| Rheumatic etiology | 4.14 | 1.47-11.63 | 0.007 | 4.14 | 1.34-12.76 | 0.01 |
| Baseline LVEDD (from 4.7 to 6 cm) | 0.65 | 0.37-1.13 | 0.12 | |||
| Baseline LVESD (from 3 to 4.3) | 0.72 | 0.43-1.22 | 0.23 | |||
| OR: Odds ratio; IQR: Interquartile range; TR: Tricuspid regurgitation; TV: Tricuspid valve; AF: Atrial fibrillation; EF: Ejection fraction; LVEDD: Left ventricular end-diastolic diameter; LVESD: Left ventricular end-systolic diameter. | ||||||
Conditional multivariable logistic regression analyses in all groups (propensity matched data)
| Variables | OR | %95 CI | |
| Sex (male reference) | 1.36 | 0.61-3.06 | 0.45 |
| Rheumatic etiology | 3.40 | 1.49-7.81 | 0.004 |
| Baseline/continue AF | 1.58 | 0.34-7.37 | 0.56 |
| Baseline diameter of tricuspid annulus (from 3.8 to 4.1) | 1.46 | 0.74-2.85 | 0.27 |
| Baseline EF% | 0.99 | 0.95-1.04 | 0.77 |
| No-TV repair (reference repair) | 3.72 | 1.45-9.56 | 0.006 |
| CI: Confidence interval; TV: Tricuspid valve; TR: Tricuspid regurgitation; AF: Atrial fibrillation; EF: Ejection fraction; Prediction of postoperative progression of (moderate-to-severe) TR in all groups. | |||
Figure 1Common support of the PS matched data distributions.
BSA: Body surface area; CBP: Cardiopulmonary bypass; HT: Hypertansion; PAB: Pulmonary artery pressure.
Figure 2Survival rates of according to the groups.